Know Cancer

or
forgot password

An Expanded Phase II Study of Hypofractionated Dose Intense Image Guided Proton Radiation Therapy for Low and Intermediate Risk Adenocarcinoma of the Prostate


Phase 2
18 Years
N/A
Open (Enrolling)
Male
Prostate Cancer

Thank you

Trial Information

An Expanded Phase II Study of Hypofractionated Dose Intense Image Guided Proton Radiation Therapy for Low and Intermediate Risk Adenocarcinoma of the Prostate


Inclusion Criteria:



- Prostate cancer.

- Gleason score 2-6 or 7.

- PSA ≤ 20 ng/ml.

Exclusion Criteria:

- Previous prostate cancer surgery or pelvic radiation.

- Prior/concurrent systemic chemotherapy for prostate cancer.

- Active inflammatory bowel disease (Crohn's disease, diverticulitis or ulcerative
colitis) affecting the rectum.

- History of proximal urethral stricture requiring dilatation.

- History of hip replacement.

- Prior intrapelvic surgery.

- Taking Saw Palmetto or methotrexate and unable or unwilling to discontinue its uses
during radiation.

- Receiving continuous and current anticoagulation with Warfarin sodium (Coumadin),
Clopidogrel bisulfate (Plavix), dabigatran etexilate mesylate (Pradaxa),enoxaparin
sodium (Lovenox), or aspirin/er dipyridamole (Aggrenox).

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Cumulative incidence of treatment-related grade 2 or higher rectal bleeding.

Outcome Time Frame:

2 years after completion of radiation therapy

Safety Issue:

Yes

Principal Investigator

Randal H. Henderson, MD, MBA

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Florida Proton Therapy Institute

Authority:

United States: Institutional Review Board

Study ID:

UFPTI 1103-PR07

NCT ID:

NCT01368055

Start Date:

September 2011

Completion Date:

September 2036

Related Keywords:

  • Prostate Cancer
  • Proton Radiation, Prostate Cancer
  • Prostatic Neoplasms

Name

Location
University of Florida Proton Therapy Institute Jacksonville, Florida  32206